Sutton Wealth Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-371
| Closed | -$16.5K | – | 1758 |
|
|
2022
Q2 | $16.5K | Sell |
371
-8
| -2% | -$355 | 0.01% | 738 |
|
|
2022
Q1 | $18.8K | Buy |
379
+6
| +2% | +$297 | 0.01% | 728 |
|
|
2021
Q4 | $19K | Buy |
373
+2
| +0.5% | +$102 | 0.01% | 715 |
|
|
2021
Q3 | $20.7K | Hold |
371
| – | – | 0.01% | 680 |
|
|
2021
Q2 | $15.9K | Hold |
371
| – | – | 0.01% | 772 |
|
|
2021
Q1 | $15.5K | Hold |
371
| – | – | 0.01% | 754 |
|
|
2020
Q4 | $17.3K | Hold |
371
| – | – | 0.01% | 657 |
|
|
2020
Q3 | $15.8K | Hold |
371
| – | – | 0.01% | 611 |
|
|
2020
Q2 | $17.8K | Hold |
371
| – | – | 0.01% | 570 |
|
|
2020
Q1 | $17.1K | Hold |
371
| – | – | 0.01% | 520 |
|
|
2019
Q4 | $22.3K | Hold |
371
| – | – | 0.01% | 561 |
|
|
2019
Q3 | $21K | Hold |
371
| – | – | 0.01% | 568 |
|
|
2019
Q2 | $20.7K | Hold |
371
| – | – | 0.01% | 569 |
|
|
2019
Q1 | $18.7K | Buy |
+371
| New | +$18.7K | 0.01% | 595 |
|
|
2018
Q4 | – | Sell |
-143
| Closed | -$9.91K | – | 1206 |
|
|
2018
Q3 | $9.91K | Buy |
+143
| New | +$9.91K | 0.01% | 785 |
|
|
2018
Q1 | – | Sell |
-109
| Closed | -$5.82K | – | 1155 |
|
|
2017
Q4 | $5.82K | Buy |
109
+22
| +25% | +$1.18K | ﹤0.01% | 873 |
|
|
2017
Q3 | $5.19K | Sell |
87
-18
| -17% | -$1.07K | ﹤0.01% | 870 |
|
|
2017
Q2 | $8.28K | Hold |
105
| – | – | 0.01% | 789 |
|
|
2017
Q1 | $8.71K | Hold |
105
| – | – | 0.01% | 746 |
|
|
2016
Q4 | $8.33K | Hold |
105
| – | – | 0.01% | 738 |
|
|
2016
Q3 | $7.35K | Buy |
+105
| New | +$7.35K | 0.01% | 745 |
|